Author: devcuration

There is a specific sound every founder eventually learns to respect. Phones ringing. Customers waiting. Silence stretching just long enough to feel expensive. PolyAI was built inside that moment. Born from the University of Cambridge Dialog Systems Group in Nov 2017, Nikola Mrkšić, Tsung-Hsien Wen, and Pei-Hao Su were not chasing louder chatbots. They were chasing understanding, across accents, industries, and the messy reality of human speech. That obsession just converted into scale. On Dec 15, 2025, PolyAI closed an $86M Series D co-led by Georgian, Hedosophia, and Khosla Ventures, with backing from NVentures, the British Business Bank, Citi Ventures,…

Read More

Clinical trials are where ambition goes to sweat. Roughly 70% of pharma R and D budgets live there, and about 90% of drug candidates never make it out alive. That is not a rounding error, that is a structural problem hiding in plain sight. Valinor Discovery stepped into that mess with a simple belief: if the industry insists on betting big, it should at least stop betting blind. Founded in Sept 2024 and emerging from stealth in May 2025, Valinor Discovery moves like a company that understands time is the most expensive reagent in biotech. December added the punctuation mark.…

Read More

Fifteen years in stealth does something to a company. It strips away noise, pitch deck theater, and the dopamine hits of premature applause. ProLynx Inc. stayed underground while biotech chased cycles, headlines, and hurry. Now it surfaces with a $70M Series A and a platform that quietly makes weekly injections look like a transitional phase. This is not a debut. This is a reveal with timing baked in. Founded in 2010 by Daniel V. Santi and Gary W. Ashley, ProLynx was never optimized for speed dating with capital. Chemistry came first. Patience followed. Their extended release linker technology was proven…

Read More

Some companies chase intelligence. RelationalAI decided to build it where the truth already lives. In 2017, Molham Aref took 30+ years of scars from fraud detection, supply chains, pricing engines, and network optimization and said the quiet part out loud. Enterprises do not suffer from a lack of data. They suffer from data that cannot reason. Berkeley became home base, Snowflake became the terrain, and decision intelligence became the obsession. This week, RelationalAI secured a $22.5M strategic investment led by Snowflake Ventures and AT&T Ventures. Not tourists. Not check writers chasing vibes. Operators. One runs the AI data cloud. The…

Read More

Clinical trials are where ambition goes to sweat. Roughly 70% of pharma R and D budgets live there, and about 90% of drug candidates never make it out alive. That is not a rounding error; that is a structural problem hiding in plain sight. Valinor Discovery stepped into that mess with a simple belief: if the industry insists on betting big, it should at least stop betting blind. Founded in Sept 2024 and emerging from stealth in May 2025, Valinor Discovery moves like a company that understands time is the most expensive reagent in biotech. December added the punctuation mark.…

Read More

SanegeneBio has been moving in silence for a while, which feels intentional for a company built on RNA interference. Founded in 2021 with a dual-engine footprint spanning Woburn, MA and R&D centers in Shanghai and Suzhou, this is what happens when patience, chemistry and institutional discipline sync up. On Dec 8, 2025, the volume turned up with a Series B exceeding $110M, led by a well-known industrial investor that chose anonymity over applause. In biotech, that kind of restraint usually signals confidence, not mystery. The architecture starts with Dr. Weimin Wang, Founder and CEO, a 25+ year veteran of oligonucleotide…

Read More

Some companies raise capital. Others raise eyebrows, blood pressure, and the collective imagination of an entire industry. Skild AI just pulled off the third one. Over $1B in Series C funding, a $14B valuation, and suddenly Pittsburgh is hosting a quiet earthquake that every robotics lab, factory floor, and VC Monday memo can feel. This is not noise. This is mass shifting. Skild AI was founded in May 2023 by Deepak Pathak and Abhinav Gupta, two Carnegie Mellon minds who spent years watching robots struggle with the same thing humans solved before language. General intelligence in the physical world. Not…

Read More

December 10, 2025 landed quietly, but Inito does not do small moments. A $29M Series B, led by Bertelsmann India Investments with Fireside Ventures returning, is not a headline grab. It is a checkpoint. Founded in 2015 by Aayush Rai and Varun AV, Inito waited until 2021 to launch a product. Six years of building before selling, which in startup math is either reckless or disciplined depending on whether you understand hardware, biology, and trust. The market is now answering that question for them. Inito operates where healthcare stops being abstract and starts being personal. A smartphone-connected flat-lens reader, a…

Read More

Protein proximity is a funny thing. In biology, it decides whether a signal whispers or shouts. In business, it decides whether an idea stays academic or turns into leverage. InduPro Therapeutics has been engineering both with intent, and December 10, 2025 made that unmistakable when Sanofi stepped in with a strategic equity investment and research collaboration focused on the bispecific PD-1 agonist program, IDP-003. InduPro Therapeutics did not show up chasing headlines. Founded in 2022 by Scientific Founder K. Christopher Garcia, Ph.D., alongside Scott Lesley, Ph.D., Rob Oslund, Ph.D., and Niyi Fadeyi, Ph.D., the company emerged from Merck’s Exploratory Science…

Read More

Somewhere between a static product page and a checkout button, e-commerce lost its nerve. It learned how to show products but forgot how to sell. Loops AI exists because that gap got personal. A broken buying experience turned into a weekend build, which turned into real revenue, which turned into a company that decided websites should stop standing there quietly and start working like trained closers. Loops AI is building what it calls Agentic Commerce, and this is not about chat bubbles pretending to be helpful. These are autonomous AI agents that sell, support, follow up, and learn like elite…

Read More